公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells | Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; HSIN-AN HOU ; Hsiao M.; HWEI-FANG TIEN | Journal of Leukocyte Biology | 16 | 14 | |
2016 | Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells | Kuo T.-C.; Chen C.-K.; KUO-TAI HUA ; Yu P.; Lee W.-J.; Chen M.-W.; YUNG-MING JENG ; Chien M.-H.; Kuo K.-T.; Hsiao M.; Kuo M.-L. | Cancer Letters | 44 | 43 | |
2010 | H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM | Chen M.-W.; KUO-TAI HUA ; Kao H.-J.; Chi C.-C.; LING-HUNG WEI ; Johansson G.; Shiah S.-G.; Chen P.-S.; YUNG-MING JENG ; TSU-YAO CHENG ; Lai T.-C.; Chang J.-S.; Jan Y.-H.; Chien M.-H.; Yang C.-J.; Huang M.-S.; Hsiao M.; Kuo M.-L. | Cancer Research | 300 | 279 | |
2017 | Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate-cysteine ligase catalytic subunit in head and neck squamous cell carcinoma | Liu C.-W.; KUO-TAI HUA ; Li K.-C.; HSIANG-FONG KAO ; RUEY-LONG HONG ; JENG-YUH KO ; Hsiao M.; Kuo M.-L.; CHING-TING TAN | Molecular Cancer Therapeutics | 42 | 40 | |
2002 | Inducible cyclooxygenase and interleukin 6 gene expressions in nasal polyp fibroblasts: Possible implication in the pathogenesis of nasal polyposis | Liu C.-M.; Hong C.-Y.; CHIA-TUNG SHUN ; Hsiao T.-Y.; Wang C.-C.; Wang J.-S.; Hsiao M.; SZE-KWAN LIN | Archives of Otolaryngology - Head and Neck Surgery | 31 | 29 | |
2014 | Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma | Li K.-C.; Hua K.-T.; Lin Y.-S.; Su C.-Y.; JENG-YUH KO ; Hsiao M.; Kuo M.-L.; CHING-TING TAN | Molecular Cancer | 51 | 50 | |
2016 | Inhibition of VEGF 165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis | Chen C.-K.; Yu W.-H.; TSU-YAO CHENG ; Chen M.-W.; Su C.-Y.; Yang Y.-C.; Kuo T.-C.; MING-TSAN LIN ; Huang Y.-C.; Hsiao M.; KUO-TAI HUA ; Hung M.-C.; Kuo M.-L. | Scientific Reports | 25 | 21 | |
2022 | Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment | Chan M.-H; Chang Z.-X; Huang C.F; Lee L.J; RU-SHI LIU ; Hsiao M. | Nanoscale Horizons | 28 | 24 | |
2015 | Keap1-Nrf2 interaction suppresses cell motility in lung adenocarcinomas by targeting the S100P protein | Chien M.-H.; Lee W.-J.; Hsieh F.-K.; Li C.-F.; TSU-YAO CHENG ; Wang M.-Y.; JIN-SHING CHEN ; Chow J.-M.; Jan Y.-H.; Hsiao M.; KUO-TAI HUA ; Kuo M.-L. | Clinical Cancer Research | 39 | 37 | |
2017 | KSRP suppresses cell invasion and metastasis through miR-23a-mediated EGR3 mRNA degradation in non-small cell lung cancer | Chien M.-H.; Lee W.-J.; Yang Y.-C.; Li Y.-L.; Chen B.-R.; TSU-YAO CHENG ; Yang P.-W.; Wang M.-Y.; Jan Y.-H.; Lin Y.-K.; JANG-MING LEE ; Hsiao M.; JIN-SHING CHEN ; KUO-TAI HUA | Biochimica et Biophysica Acta - Gene Regulatory Mechanisms | 28 | 26 | |
2014 | Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment | Chen C.-K.; CHING-YAO YANG ; Hua K.-T.; MING-CHIH HO ; Johansson G.; YUNG-MING JENG ; CHIUNG-NIEN CHEN ; Chen M.-W.; Lee W.-J.; Su J.-L.; Lai T.-C.; Chou C.-C.; Ho B.-C.; Chang C.-F.; PO-HUANG LEE ; KING-JEN CHANG ; Hsiao M.; MING-TSAN LIN ; Kuo M.-L. | Hepatology | 48 | 45 | |
2018 | Leukocyte cell-derived chemotaxin 2 retards non-small cell lung cancer progression through antagonizing MET and EGFR activities | Hung W.-Y.; Chang J.-H.; Cheng Y.; Chen C.-K.; Chen J.-Q.; KUO-TAI HUA ; Cheng C.-W.; Hsiao M.; Chung C.-L.; Lee W.-J.; Chien M.-H. | Cellular Physiology and Biochemistry | 12 | 11 | |
2016 | Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis | Lin C.-W.; Yang W.-E.; Lee W.-J.; KUO-TAI HUA ; Hsieh F.-K.; Hsiao M.; Chen C.-C.; Chow J.-M.; Chen M.-K.; Yang S.-F.; Chien M.-H. | Carcinogenesis | 60 | 59 | |
2003 | Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas | Chen H.-C.; Chu R.Y.; PING-NING HSU ; Hsu P.-I.; Lu J.-Y.; Lai K.-H.; Tseng H.-H.; Chou N.-H.; Huang M.-S.; Tseng C.-J.; Hsiao M. | Cancer letters | 104 | 88 | |
2020 | Magnetically Guided Theranostics: Optimizing Magnetic Resonance Imaging with Sandwich-Like Kaolinite-Based Iron/Platinum Nanoparticles for Magnetic Fluid Hyperthermia and Chemotherapy | Chan M.-H; Hsieh M.-R; Liu R.-S; Wei D.-H; Hsiao M.; RU-SHI LIU | Chemistry of Materials | 26 | 25 | |
2011 | miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans | Chen P.-S.; Su J.-L.; Cha S.-T.; Tarn W.-Y.; Wang M.-Y.; Hsu H.-C.; MING-TSAN LIN ; CHIA-YU CHU ; Hua K.-T.; CHIUNG-NIEN CHEN ; Kuo T.-C.; KING-JEN CHANG ; Hsiao M.; Chang Y.-W.; JIN-SHING CHEN ; PAN-CHYR YANG ; Kuo M.-L. | Journal of Clinical Investigation | 122 | 110 | |
2013 | MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol | Yu Y.-H.; Chen H.-A.; Chen P.-S.; Cheng Y.-J.; Hsu W.-H.; Chang Y.-W.; Chen Y.-H.; Jan Y.; Hsiao M.; Chang T.-Y.; Liu Y.-H.; YUNG-MING JENG ; Wu C.-H.; Huang M.-T.; Su Y.-H.; Hung M.-C.; Chien M.-H.; Chen C.-Y.; Kuo M.-L.; Su J.-L. | Oncogene | 121 | 105 | |
2014 | MiR326 maturation is crucial for VEGF-C-driven cortactin expression and esophageal cancer progression | Hong C.-C.; Chen P.-S.; Chiou J.; Chiu C.-F.; CHING-YAO YANG ; Hsiao M.; Chang Y.-W.; Yu Y.-H.; Hung M.-C.; Hsu N.-W.; Shiah S.-G.; Hsu N.-Y.; Su J.-L. | Cancer Research | 29 | 28 | |
2014 | MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients | Su C.-Y.; YI-CHENG CHANG ; Chan Y.-C.; Lin T.-C.; Huang M.-S.; Yang C.-J.; Hsiao M. | European Journal of Surgical Oncology | 29 | 28 | |
2018 | N-α-acetyltransferase 10 protein promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas | Chien M.-H.; Lee W.-J.; Yang Y.-C.; Tan P.; Pan K.-F.; Liu Y.-C.; Tsai H.-C.; Hsu C.-H.; Wen Y.-C.; Hsiao M.; KUO-TAI HUA | Cancer Letters | 25 | 25 |